Empowering Your Lab with a Proactive Approach

Oct 30, 2017 | Blogs, Software, Technology | 0 comments

Do you stay in the lab day and night, waiting for a sample run to finish? Or do you set your instrument to run and trust that it will operate as intended while you are away? Is there a way you can have a support network behind you to help to ensure the smooth operation of your instruments?

There most certainly is. With StatusScope Remote Monitoring, you can securely connect to your lab from anywhere, to stay ahead of potential errors. 

Don’t Take Our Word for It
Recently, our support desk was alerted to a situation in which remote monitoring data showed a lab’s room temperature at 35˚ C. While a mass spec can run at this temperature, is still considered warm. 

Our team immediately alerted the customer to the potential issue. It turns out, as they were fixing their HVAC system, their lab temperature increased. Increased lab temperatures are a not an ideal environment for operating a mass spec and often can result in workflow interruption.

Without the StatusScope service, this lab would not be alerted and would only be aware of the situation if they were actively observing their operation.

StatusScope Service Must-Haves
Today’s StatusScope service alerts go beyond “your system is not working.” You can now receive new alarms, simplified status lights to avoid confusion and ever-important support for your systems.

In the example above, an instrument issue was detected—an increased ambient temperature, that could interrupt workflow, even if the instrument is running fine. With StatusScope service, workflow interruption warnings will alert you of such instances.

Intelligent alarms go a step further by sending you alerts if your instrument is down or whether there is an issue that could cause a failure in the short-term.

Streamlined error codes, on the other hand, make it easy to identify the issue as the SCIEX Technical Support team will receive instant alerts. Working in tandem with your lab, we can try a remote fix or schedule a service call. Up to 50% of issues can be fixed remotely, so you can potentially save time getting your instrument up and running again. 

Finally, simplified status indicators display critical information, including:

  • Disconnected: Asset is disconnected and not reporting to our servers
  • Failure: We have identified a failure or indications of possible future failure
  • Good: System is connected, reporting and ready to run
  • Running: System is acquiring data

StatusScope Service is Workflow Focused
Today’s mass spec service goes beyond phone calls and subsequent site visits. It is more about empowering your lab to react and remedy issues as quickly as possible proactively.

The new alarms and warnings available with the StatusScope service help you eliminate the risk that ties with instrument downtime by reducing the time to resolution. 

With the StatusScope service you can:

  • Access throughput and asset utilization reports
  • Essential insights to understand how often any one instrument, no matter its location, is available for use and running based on an instrument’s operating parameters
  • Minimize downtime. Up to 50 percent of support cases can be resolved without a service engineer visit.

Want to learn more about StatusScope service? Fill out the form on the right to download the info kit.

PFAS testing: 2024 in review and what to expect for 2025

For as long as PFAS persist in the environment, there is no doubt they will persist in our conversations as environmental scientists. Globally, PFAS contamination has been detected in water supplies, soil and even in the blood of people and wildlife. Different countries are at various stages of addressing PFAS contamination and many governments have set regulatory limits and are working on assessing the extent of contamination, cleaning up affected sites and researching safer alternatives.

Inside the box: Acoustic ejection mass spectrometry for drug discovery

On average, it takes 10-15 years and 1-2 billion dollars to approve a new pharmaceutical for clinical use. Since approximately 90% of new drug candidates fail in clinical development, the ability to make early, informed and accurate decisions on the safety and efficacy of new hits and leads is key to increasing the chances of success.

Unveiling the power of ZT Scan DIA: Insights from Ludwig Sinn’s presentation at World HUPO Congress 2024

In a recent presentation at the World HUPO Congress 2024, Ludwig Sinn from the Ralser lab shared exciting advancements in proteomics research, focusing on the innovative ZT Scan DIA acquisition modes developed in collaboration with SCIEX. Let us explore the key highlights and benefits of this innovative technology.

Posted by

0 Comments

Submit a Comment

Wordpress Social Share Plugin powered by Ultimatelysocial